Healthcare Technology Featured Article

April 19, 2012

PositiveID's iglucose Monitor on Display at CTIA Conference


PositiveID Corporation, a provider of technologies for diabetes management as well as airborne bio-threat detection systems for America's homeland defense, today announced that the FDA has approved its iglucose mobile health system for diabetes management.

PositiveID's iglucose uses mobile technology to help individuals with diabetes manage their conditions. Data from glucometers is transmitted to an iglucose diabetes management portal, so that glucose readings can be shared with family members and healthcare professionals.

According to officials, logbooks are no longer necessary, eliminating some costs and time constraints as the device allows individuals with diabetes to better manage their conditions themselves while family members receive text messages of a patient’s glucose levels. This is especially helpful for parents of children with diabetes who aer at school or away from them. iglucose does not require the use of a cell phone or a wireless plan, according to the company.

Diabetics must measure their glucose, or blood sugar, levels because the amount of glucose stored in the body can sometimes mean the difference between life and death. If measurements come up lacking, either too much or too little glucose in the blood, other steps may need to be taken, all of which is picked up by glucose monitoring systems and relayed to healthcare professionals or caregivers.

Tests conducted as part of the iglucose FDA review process found that 100 percent of consumers were able to use the device, regardless of age. All that is required is for users to connect their glucometer to iglucose and push a button. The iglucose system then creates a variety of reports, according to the user's preferences via online access, email, fax or SMS text.

iglucose will be featured at the CTIA Emerging Technology (E-Tech) Awards Showcase at the International CTIA Wireless 2012 show from May 8-10, at the Ernest N. Morial Convention Center in New Orleans, La.

Too little glucose can cause dizziness, fainting, fast heartbeat and fatigue and is actually more dangerous than too much glucose in the blood.

Over 25 million children and adults in the United States — 8.3 percent of the population — have diabetes in the U.S. An additional 18 million-plus will be diagnosed this year, and an alarming seven million have it and don’t know it.




Edited by Carrie Schmelkin
Get stories like this delivered straight to your inbox. [Free eNews Subscription]




SHARE THIS ARTICLE



FREE eNewsletter

Click here to receive your targeted Healthcare Technology Community eNewsletter.
[Subscribe Now]